Paper41522129
Construction and validation of a nomogram for predicting chronic obstructive pulmonary disease with bronchiectasis.
Feng Z and 4 others. J Thorac Dis, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Construction and validation of a nomogram for predicting chronic obstructive pulmonary disease with bronchiectasis. Papers, record 41522129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41522129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction and validation of a nomogram for predicting chronic obstructive pulmonary disease with bronchiectasis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38061380 | GOLD COPD report: 2024 update. | Lancet Respir Med | 2024 | https://conductscience.org/library/papers/38061380 | PubMed |
| 2 | 36858443 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. | Eur Respir J | 2023 | https://conductscience.org/library/papers/36858443 | PubMed |
| 3 | 38782469 | Bronchiectasis management in adults: state of the art and future directions. | Eur Respir J | 2024 | https://conductscience.org/library/papers/38782469 | PubMed |
| 4 | 32265292 | Impact of Radiographic Bronchiectasis in COPD. | Respir Care | 2020 | https://conductscience.org/library/papers/32265292 | PubMed |
| 5 | 37455331 | Post-tuberculosis lung disease and chronic obstructive pulmonary disease. | Chin Med J (Engl) | 2023 | https://conductscience.org/library/papers/37455331 | PubMed |
| 6 | 35456002 | Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases. | Cells | 2022 | https://conductscience.org/library/papers/35456002 | PubMed |
| 7 | 39655338 | Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications. | Ther Adv Pulm Crit Care Med | 2024 | https://conductscience.org/library/papers/39655338 | PubMed |
| 8 | 34820447 | ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group. | ERJ Open Res | 2021 | https://conductscience.org/library/papers/34820447 | PubMed |
| 9 | 35236561 | Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome. | Clin Chest Med | 2022 | https://conductscience.org/library/papers/35236561 | PubMed |
| 10 | 35062325 | Outer Membrane Vesicles (OMVs) of Pseudomonas aeruginosa Provide Passive Resistance but Not Sensitization to LPS-Specific Phages. | Viruses | 2022 | https://conductscience.org/library/papers/35062325 | PubMed |
| 11 | 35399263 | Mucus Clearance Strategies in Mechanically Ventilated Patients. | Front Physiol | 2022 | https://conductscience.org/library/papers/35399263 | PubMed |
| 12 | 38960613 | Pathophysiology and genomics of bronchiectasis. | Eur Respir Rev | 2024 | https://conductscience.org/library/papers/38960613 | PubMed |
| 13 | 33886788 | Risk factors for bronchiectasis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. | Clinics (Sao Paulo) | 2021 | https://conductscience.org/library/papers/33886788 | PubMed |
| 14 | 39318994 | Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39318994 | PubMed |
| 15 | 38940273 | Analysis of clinical characteristics, prognosis and influencing factors in patients with bronchiectasis-chronic obstructive pulmonary disease overlap syndrome: A prospective study for more than five years. | J Glob Health | 2024 | https://conductscience.org/library/papers/38940273 | PubMed |
| 16 | 38263115 | Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38263115 | PubMed |
| 17 | 27442646 | Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27442646 | PubMed |
| 18 | 34490307 | Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34490307 | PubMed |
| 19 | 30049739 | The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. | Eur Respir J | 2018 | https://conductscience.org/library/papers/30049739 | PubMed |
| 20 | 29957282 | Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study. | Respir Med | 2018 | https://conductscience.org/library/papers/29957282 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41522129
GET https://conductscience.org/api/papers/v1/41522129/references?page=2